On Wednesday, Gregory Rigano, an advisor to the Stanford University School of Medicine, claimed that a world-renowned French researcher had tested a promising cure for coronavirus.
He tweeted: “Full peer-reviewed study has been released by Didier Raoult MD, PhD. After 6 days 100% of patients treated with HCQ + Azithromycin were virologically cured.”
Appearing on Fox News Wednesday night, Rigano followed up by stating:
And I’m here to report that as of this morning, about 5:00 this morning, a well-controlled peer-reviewed study carried out by the most eminent infectious disease specialist in the world—Didier Raoult, MD, PhD—out of the south of France, in which he enrolled 40 patients, again, a well-controlled peer review study, that showed a 100 percent cure rate against coronavirus. The study was released this morning on my Twitter account, @Riganoesq as well as our most recent website, @covidtrial.io. The study was recently accepted to the International Journal of Antimicrobial Agents by Elsevier.
Rigano continued, “In fact to be able to cure a virus was said to be mathematically impossible, and the first company that did it was a small biotech called Pharmacet that was acquired by Gilead Sciences in a cure for hepatitis C. What we’re here to announce is a second cure to a virus of all time.”
On Monday, The Daily Wire reported that an Australian team had announced they might have found a cure for coronavirus, and it was in a similar vein:
According to infectious disease experts at the University of Queensland in Brisbane, Australia, they may have found a treatment that could possibly eliminate the coronavirus. “University of Queensland Centre for Clinical Research director Professor David Paterson told news.com.au today they have seen two drugs used to treat other conditions wipe out the virus in test tubes,” News.com.aureported Monday.
The two medications Paterson referred to are Chloroquine, an anti-malarial drug, and HIV-suppressing combination lopinavir/ritonavir. Paterson told the outlet that it seemed reasonable to call the drugs “a treatment or a cure … It’s a potentially effective treatment. Patients would end up with no viable coronavirus in their system at all after the end of therapy.”
According to covidtrial.io, here are the backgrounds for Didier Raoult and another doctor involved in the study:
Didier Raoult created the Rickettsia Unit at Aix-Marseille University. Since 2008, Dr. Raoult has served as the director of URMITE (Research Unit in Infectious and Tropical Emergent Diseases), collaborating with CNRS (National Center for the Scientific Research), IRD (Research for the Development Institute), INSERM (National Institute of Health and Medical Research) and Aix Marseille University. His laboratory employs more than 200 people, including nearly 100 active researchers who publish between 250 and 350 papers per year and have produced over 50 patents.
Dr. Chandra Duggirala has a bio that states:
He founded Novobionics, a medical device company to treat diabetes and obesity non-invasively and invented it’s double sleeve technology. He lead the company through preclinical trials and several US and international patents. He is also the Principal Investigator of the Reset-Youth trial, one of the largest clinical trials for investigating the reversibility of epigenetic markers of aging. He also founded a software company at the intersection of nutritional biology and A.I.